Hellings PW, Fokkens WJ, Orlandi R, Adriaensen GF, Alobid I, Baroody FM, et al. The EUFOREA pocket guide for chronic rhinosinusitis. Rhin. 2022. https://doi.org/10.4193/Rhin22.344.
Fokkens WJ, Viskens A-S, Backer V, Conti D, De Corso E, Gevaert P, et al. EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023. Rhinology. 2023;61(3):194–202. https://doi.org/10.4193/Rhin22.489.
Article CAS PubMed Google Scholar
Mullol J, Sastre J, Domínguez-Ortega J, Blanco- Aparicio M, Castillo Vizuete JA, Alobid I, et al. Prevalence of chronic rhinosinusitis without/with nasal polyps according to severity in Spain. Rhinology. 2024. https://doi.org/10.4193/Rhin23.341.
Fokkens WJ, De Corso E, Backer V, Bernal-Sprekelsen M, Bjermer L, Von Buchwald C, et al. EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP. Rhinology. 2024. https://doi.org/10.4193/Rhin23.415.
Sedaghat AR, Fokkens WJ, Lund VJ, Hellings PW, Kern RC, Reitsma S, et al. Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study. Rhinology. 2023;61:519–30. https://doi.org/10.4193/Rhin23.335.
Article CAS PubMed Google Scholar
Ebina-Shibuya R, Leonard WJ. Role of thymic stromal lymphopoietin in allergy and beyond. Nat Rev Immunol. 2023;23:24–37. https://doi.org/10.1038/s41577-022-00735-y.
Article CAS PubMed Google Scholar
Smolinska S, Antolín-Amérigo D, Popescu F-D, Jutel M. Thymic Stromal Lymphopoietin (TSLP), Its Isoforms and the Interplay with the Epithelium in Allergy and Asthma. IJMS. 2023;24:12725. https://doi.org/10.3390/ijms241612725.
Article CAS PubMed PubMed Central Google Scholar
Menzies-Gow A, Corren J, Bourdin A, Chupp G, Israel E, Wechsler ME, et al. Tezepelumab in Adults and Adolescents with Severe. Uncontrolled Asthma N Engl J Med. 2021;384:1800–9. https://doi.org/10.1056/NEJMoa2034975.
Article CAS PubMed Google Scholar
Gauvreau GM, Hohlfeld JM, FitzGerald JM, Boulet L-P, Cockcroft DW, Davis BE, et al. Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma. Eur Respir J. 2023;61:2201193. https://doi.org/10.1183/13993003.01193-2022.
Article CAS PubMed PubMed Central Google Scholar
Hoy SM. Tezepelumab: First Approval. Drugs. 2022;82:461–8. https://doi.org/10.1007/s40265-022-01679-2.
Article CAS PubMed Google Scholar
Khan A, Vandeplas G, Huynh TMT, Joish VN, Mannent L, Tomassen P, et al. The Global Allergy and Asthma European Network (GALEN rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps. Rhin. 2019;57:32–42. https://doi.org/10.4193/Rhin17.255.
Khan AH, Gouia I, Kamat S, Johnson R, Small M, Siddall J. Prevalence and Severity Distribution of Type 2 Inflammation-Related Comorbidities Among Patients with Asthma, Chronic Rhinosinusitis with Nasal Polyps, and Atopic Dermatitis. Lung. 2023;201:57–63. https://doi.org/10.1007/s00408-023-00603-z.
Article PubMed PubMed Central Google Scholar
Canonica GW, Malvezzi L, Blasi F, Paggiaro P, Mantero M, Senna G, et al. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry. Respir Med. 2020;166:105947. https://doi.org/10.1016/j.rmed.2020.105947.
Håkansson K, Bachert C, Konge L, Thomsen SF, Pedersen AE, Poulsen SS, et al. Airway Inflammation in Chronic Rhinosinusitis with Nasal Polyps and Asthma: The United Airways Concept Further Supported. PLoS ONE. 2015;10:e0127228. https://doi.org/10.1371/journal.pone.0127228.
Article CAS PubMed PubMed Central Google Scholar
Bachert C, Vignola AM, Gevaert P, Leynaert B, Van Cauwenberge P, Bousquet J. Allergic rhinitis, rhinosinusitis, and asthma: one airway disease. Immunol Allergy Clin North Am. 2004;24:19–43. https://doi.org/10.1016/S0889-8561(03)00104-8.
Wang M, Bu X, Luan G, Lin L, Wang Y, Jin J, et al. Distinct type 2-high inflammation associated molecular signatures of chronic rhinosinusitis with nasal polyps with comorbid asthma. Clin Transl Allergy. 2020;10:26. https://doi.org/10.1186/s13601-020-00332-z.
Article CAS PubMed PubMed Central Google Scholar
Chapurin N, Wu J, Labby AB, Chandra RK, Chowdhury NI, Turner JH. Current insight into treatment of chronic rhinosinusitis: Phenotypes, endotypes, and implications for targeted therapeutics. J Allergy Clin Immunol. 2022;150:22–32. https://doi.org/10.1016/j.jaci.2022.04.013.
Article CAS PubMed PubMed Central Google Scholar
Bachert C, Pawankar R, Zhang L, Bunnag C, Fokkens WJ, Hamilos DL, et al. ICON: chronic rhinosinusitis. World Allergy Organ J. 2014;7:25. https://doi.org/10.1186/1939-4551-7-25.
Article PubMed PubMed Central Google Scholar
Laidlaw TM, Mullol J, Woessner KM, Amin N, Mannent LP. Chronic Rhinosinusitis with Nasal Polyps and Asthma. J Allergy Clin Immunol. 2021;9:1133–41. https://doi.org/10.1016/j.jaip.2020.09.063.
Hulse KE, Stevens WW, Tan BK, Schleimer RP. Pathogenesis of nasal polyposis. Clin Experimental Allergy. 2015;45:328–46. https://doi.org/10.1111/cea.12472.
Cho SH, Hamilos DL, Han DH, Laidlaw TM. Phenotypes of Chronic Rhinosinusitis. J Allergy Clin Immunol. 2020;8:1505–11. https://doi.org/10.1016/j.jaip.2019.12.021.
Huang C-C, Chang P-H, Huang Y-L, Lee T-J, Huang C-C, Wu P-W. Clinical Characteristics of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps in Adolescents. JAA. 2023;16:1197–206. https://doi.org/10.2147/JAA.S437876.
Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, et al. Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP. Nat Immunol. 2002;3:673–80. https://doi.org/10.1038/ni805.
Article CAS PubMed Google Scholar
Reche PA, Soumelis V, Gorman DM, Clifford T, Liu M, Travis M, et al. Human Thymic Stromal Lymphopoietin Preferentially Stimulates Myeloid Cells. J Immunol. 2001;167:336–43. https://doi.org/10.4049/jimmunol.167.1.336.
Article CAS PubMed Google Scholar
Ito T, Wang Y-H, Duramad O, Hori T, Delespesse GJ, Watanabe N, et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med. 2005;202:1213–23. https://doi.org/10.1084/jem.20051135.
Article CAS PubMed PubMed Central Google Scholar
Wei Y, Ma R, Zhang J, Wu X, Yu G, Hu X, et al. Excessive periostin expression and Th2 response in patients with nasal polyps: association with asthma. J Thorac Dis. 2018;10:6585–97. https://doi.org/10.21037/jtd.2018.11.12.
Article PubMed PubMed Central Google Scholar
Dogan M, Sahin M, Yenisey C. Increased TSLP, IL-33, IL-25, IL-19, IL 21 and amphiregulin (AREG) levels in chronic rhinosinusitis with nasal polyp. Eur Arch Otorhinolaryngol. 2019. https://doi.org/10.1007/s00405-019-05379-8.
Liu T, Zhao F, Xie C, Liu A-M, Li T-L, Chen X, et al. Role of Thymic Stromal Lymphopoietin in the Pathogenesis of Nasal Polyposis. Am J Med Sci. 2011;341:40–7. https://doi.org/10.1097/MAJ.0b013e3181f20489.
Wang B-F, Cao P-P, Norton JE, Poposki JA, Klingler AI, Suh LA, et al. Evidence that oncostatin M synergizes with IL-4 signaling to induce TSLP expression in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2023;151:1379-1390.e11. https://doi.org/10.1016/j.jaci.2022.11.029.
留言 (0)